These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. Peng CC, Glassman PA, Marks IR, Fowler C, Castiglione B, Good CB. J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659 [Abstract] [Full Text] [Related]
3. The effect of the introduction of a nationwide DUR system where local DUR systems are operating--The Korean experience. Yang JH, Kim M, Park YT, Lee EK, Jung CY, Kim S. Int J Med Inform; 2015 Nov; 84(11):912-9. PubMed ID: 26363001 [Abstract] [Full Text] [Related]
4. Physicians' and pharmacists' perceptions on real-time drug utilization review system: a nationwide survey. Lee SM, Lee SO, Kim DS. Int J Qual Health Care; 2017 Oct 01; 29(5):634-641. PubMed ID: 28992160 [Abstract] [Full Text] [Related]
5. Evaluation of the pilot program on the real-time drug utilization review system in South Korea. Heo JH, Suh DC, Kim S, Lee EK. Int J Med Inform; 2013 Oct 01; 82(10):987-95. PubMed ID: 23910897 [Abstract] [Full Text] [Related]
6. The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies. Berger FA, van der Sijs H, van Gelder T, van den Bemt PMLA. Ther Adv Drug Saf; 2021 Oct 01; 12():2042098621996098. PubMed ID: 33708374 [Abstract] [Full Text] [Related]
7. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis. Dechanont S, Maphanta S, Butthum B, Kongkaew C. Pharmacoepidemiol Drug Saf; 2014 May 01; 23(5):489-97. PubMed ID: 24616171 [Abstract] [Full Text] [Related]
8. Evaluation of preventable adverse drug reactions by implementation of the nationwide network of prospective drug utilization review program in Korea. Lee J, Noh Y, Lee S. PLoS One; 2018 May 01; 13(4):e0195434. PubMed ID: 29641617 [Abstract] [Full Text] [Related]
9. Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs. Berger FA, van der Sijs H, van Gelder T, Kuijper AFM, van den Bemt PMLA, Becker ML. Int J Med Inform; 2021 Jan 01; 145():104329. PubMed ID: 33181445 [Abstract] [Full Text] [Related]
10. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Fillenbaum GG, Hanlon JT, Landerman LR, Artz MB, O'Connor H, Dowd B, Gross CR, Boult C, Garrard J, Schmader KE. Am J Geriatr Pharmacother; 2004 Jun 01; 2(2):92-101. PubMed ID: 15555485 [Abstract] [Full Text] [Related]
11. How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients? Bucşa C, Farcaş A, Cazacu I, Leucuta D, Achimas-Cadariu A, Mogosan C, Bojita M. Eur J Intern Med; 2013 Jan 01; 24(1):27-33. PubMed ID: 23041466 [Abstract] [Full Text] [Related]
12. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. Monane M, Matthias DM, Nagle BA, Kelly MA. JAMA; 1998 Oct 14; 280(14):1249-52. PubMed ID: 9786375 [Abstract] [Full Text] [Related]
13. Physician and pharmacist satisfaction and clinical needs for the real-time medication surveillance program in South Korea. Shin SM, Kim HA, Song I, Jeon HL, Shin JY. BMC Health Serv Res; 2019 Nov 06; 19(1):805. PubMed ID: 31694628 [Abstract] [Full Text] [Related]
14. Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, Purssell RA. Ann Emerg Med; 2010 Jun 06; 55(6):493-502.e4. PubMed ID: 20005010 [Abstract] [Full Text] [Related]
15. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis. Dieu LW, Leuppi-Taegtmeyer AB, van den Anker J, Trachsel D, Gotta V. Swiss Med Wkly; 2019 Aug 12; 149():w20103. PubMed ID: 31422575 [Abstract] [Full Text] [Related]
16. Drug-drug interactions in pediatric oncology patients. Balk TE, van der Sijs IH, van Gelder T, Janssen JJB, van der Sluis IM, van Leeuwen RWF, Engels FK. Pediatr Blood Cancer; 2017 Jul 12; 64(7):. PubMed ID: 28205376 [Abstract] [Full Text] [Related]
17. Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study. Marino A, Capogrosso-Sansone A, Tuccori M, Bini G, Calsolaro V, Mantarro S, Convertino I, Pasqualetti G, Orsitto E, Santini M, Monzani F, Blandizzi C, ANCESTRAL-ED Study Group. Expert Opin Drug Saf; 2016 Dec 12; 15(sup2):45-50. PubMed ID: 27875918 [Abstract] [Full Text] [Related]
18. Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea. Yeom JH, Park JS, Oh OH, Shin HT, Oh JM. Ann Pharmacother; 2005 Nov 12; 39(11):1918-23. PubMed ID: 16219902 [Abstract] [Full Text] [Related]
19. Toward safer prescribing: evaluation of a prospective drug utilization review system on inappropriate prescriptions, prescribing patterns, and adverse drug events and related health expenditure in South Korea. Kim SJ, Han KT, Kang HG, Park EC. Public Health; 2018 Oct 12; 163():128-136. PubMed ID: 30145461 [Abstract] [Full Text] [Related]
20. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system. Toivo TM, Mikkola JA, Laine K, Airaksinen M. Res Social Adm Pharm; 2016 Oct 12; 12(4):559-68. PubMed ID: 26459026 [Abstract] [Full Text] [Related] Page: [Next] [New Search]